Skip to main content

Advertisement

SpringerLink
Log in

Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

There is an intimate relation between disturbance in survivin and SMAC/DIABLO expressions and cancer formation in many tissues; however, this was not confirmed in the primary breast cancer. The aim of this study was to evaluate the relationship between survivin and SMAC/DIABLO mRNA expressions in primary breast cancer using RT-PCR and their relationship to some of the risk factors (age, family history, breast-feeding, use of contraceptive pills and hormonal receptors). Breast cancer tissues were studied for the detection of the mRNA expression of survivin and SMAC/DIABLO. This was done by qualitative reverse transcription–polymerase chain reaction (RT-PCR). SMAC/DIABLO mRNA was detected by RT-PCR only in 1 sample in breast cancer tissues (6.25%). However, it was expressed in 16 out of 25 (64%) of the benign tumor tissues (P = 0.00). In contrast, survivin mRNA was highly expressed in breast cancer tissues, 36 out of 48 (75%) (P = 0.00), while its expression was very low in benign tumor tissues, only 1 out of 37 (2.7%) (P = 0.00). Expressions of SMAC/DIABLO and survivin were significantly reciprocal in breast cancer and benign tumor tissues. SMAC/DIABLO inhibits apoptosis of breast cancer cells by suppression of survivin. These two genes probably form an important link in the signaling pathway of formation of breast cancer cells, which may be chosen as therapeutic targets in the primary breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917. doi:10.1002/ijc.25516.

    Article  PubMed  CAS  Google Scholar 

  2. Abbas H, Elyamany A, Salem M, Salem A, Binzaid S, Gamal B. The optimal sequence of radiotherapy and chemotherapy in adjuvant treatment of breast cancer. Int Arch Med. 2011;4(1):35.

    Article  PubMed  Google Scholar 

  3. Rusiecki JA, Holford TR, Zahm SH, Zheng T. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detect Prev. 2005;29:419–26.

    Article  PubMed  CAS  Google Scholar 

  4. Holcik M, Korneluk RG. XIAP, the guardian angel. Nat Rev Mol Cell Biol. 2001;2(7):550–6.

    Article  PubMed  CAS  Google Scholar 

  5. Goyal L. Cell death inhibition: keeping caspases in check. Cell. 2001;104:805–8.

    Article  PubMed  CAS  Google Scholar 

  6. Song Z, Yao X, Wu M. Direct interaction between Survivin and SMAC/DIABLO is essential for the anti-apoptotic activity of Survivin during taxol-induced apoptosis. J Biol Chem. 2003;278:23130–40.

    Article  PubMed  CAS  Google Scholar 

  7. Strasser A, Cory S, Adams JM. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J. 2011;30(18):3667–83. doi:10.1038/emboj.2011.307.

    Article  PubMed  CAS  Google Scholar 

  8. Du C, Fang M, Li Y, Li L, Wang X. SMAC, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 2000;102:33–42.

    Article  PubMed  CAS  Google Scholar 

  9. Adrain C, Creagh EM, Martin SJ. Apoptosis-associated release of SMAC/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J. 2001;20:6627–36.

    Article  PubMed  CAS  Google Scholar 

  10. Keane RW, Kraydieh S, Lotocki G, Alonso OF, Aldana P, Dietrich WD. Apoptotic and antiapoptotic mechanisms after traumatic brain injury. J Cereb Blood Flow Metab. 2001;21:1189–98.

    Article  PubMed  CAS  Google Scholar 

  11. Sugawara T, Noshita N, Lewen A, Gasche Y, Ferrand-Drake M, Fujimura M, et al. Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J Neurosci. 2002;22:209–17.

    PubMed  CAS  Google Scholar 

  12. Saito A, Hayashi T, Okuno S, Ferrand-Drake M, Chan PH. Interaction between XIAP and SMAC/DIABLO in the mouse brain after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2003;23:1010–9.

    Article  PubMed  CAS  Google Scholar 

  13. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 1999;18:5242–51.

    Article  PubMed  CAS  Google Scholar 

  14. Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, Lemoine NR, et al. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem. 2002;277:439–44.

    Article  PubMed  CAS  Google Scholar 

  15. Duckett CS, Nava VE, Gedrich RW, Clem RJ, Van Dongen JL, Gilfillan MC, et al. A conserved family of cellular genes related to the baculovirus IAP gene and encoding apoptosis inhibitors. EMBO J. 1996;15:2685–94.

    PubMed  CAS  Google Scholar 

  16. Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, et al. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem. 1998;273:7787–90.

    Article  PubMed  CAS  Google Scholar 

  17. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, et al. A conserved XIAP-interaction motif in caspase-9 and SMAC/DIABLO regulates caspase activity and apoptosis. Nature. 2001;410:112–6.

    Article  PubMed  CAS  Google Scholar 

  18. Salako SE. The declaration of Helsinki 2000: ethical principles and the dignity of difference. Med Law. 2006;25(2):341–54.

    PubMed  CAS  Google Scholar 

  19. Discovery Studio Gene v1.5 from Accelrys primer designing program, USA. 2007.

  20. Wobser H, Dorn C, Weiss TS, Amann T, Bollheimer C, Büttner R, Schölmerich J, Hellerbrand C. Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res. 2009;19:996–1005. doi:10.1038/cr.2009.73.

    Article  PubMed  CAS  Google Scholar 

  21. DeSantis C, Howlader N, Cronin KA, Jemal A. Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev. 2011;20(5):733–9.

    Article  PubMed  Google Scholar 

  22. Ijaduola TG, Smith EB. Pattern of breast cancer among white-American, African-American, and nonimmigrant west-African women. J Natl Med Assoc. 1998;90(9):547–51.

    PubMed  CAS  Google Scholar 

  23. Vorobiof DA, Sitas F, Vorobiof G. Breast cancer incidence in South Africa. J Clin Oncol. 2001;19(18):125S–7S.

    PubMed  CAS  Google Scholar 

  24. Reeves GK, Beral V, Green J, Gathani T, Bull D. Hormonal therapy for menopause and breast cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol. 2002;7:910–8.

    Article  Google Scholar 

  25. Lambrechts S, Decloedt J, Neven P. Breast cancer prevention: lifestyle changes and chemoprevention. Acta Clin Belg. 2011;66(4):283–92.

    PubMed  CAS  Google Scholar 

  26. Freudenheim JL, Marshall JR, Vena JE. Lactation history and breast cancer risk. Am J Epidemiol. 1997;146:932–8.

    Article  PubMed  CAS  Google Scholar 

  27. Furberg H, Newman B, Moorman P, Millikan R. Lactation and breast cancer risk. Int J Epidemiol. 1999;28:396–402.

    Article  PubMed  CAS  Google Scholar 

  28. Zheng T, Holford TR, Mayne ST, Owens PH, Zhang Y, Zhang B, Boyle P, Zahm SH. Lactation and breast cancer risk: a case–control study in Connecticut. Br J Cancer. 2001;84(11):1472–6.

    Article  PubMed  CAS  Google Scholar 

  29. Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, Bernstein L, Malone KE, Ursin G, Strom BL, Norman SA, Wingo PA, Burkman RT, Berlin JA, Simon MS, Spirtas R, Weiss LK. Oral contraceptives and the risk of breast cancer. N Engl J Med. 2002;346(26):2025–32.

    Article  PubMed  CAS  Google Scholar 

  30. Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol. 2004;190(4):S5–22.

    Article  PubMed  CAS  Google Scholar 

  31. Monzo M, Rosell R, Felip E, Astudillo J, Sánchez JJ, Maestre J, Martín C, Font A, Barnadas A, Abad A. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol. 1999;17(7):2100–4.

    PubMed  CAS  Google Scholar 

  32. Ryan B, O’Donovan N, Browne B, O’Shea C, Crown J, Hill ADK, McDermott E, O’Higgins N, Duffy MJ. Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer, molecular diagnostics. Br J Cancer. 2004;92:120–4.

    Article  Google Scholar 

  33. O`Driscoll L, Linhan R, Kennedybc M, Cronina D, Purcellbc R, Glynna S, McDermottd EW, Hilld AD, O’Higginsd NJ, Parkinsone M, Clynesa M. Lack of prognostic significance of survivin, survivin-ΔEx3, survivin-2B, galectin3, bag-1, bax-α and MRP-1 mRNAs in breast cancer. Cancer Lett. 2003;201:225–36.

    Article  CAS  Google Scholar 

  34. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 2000;6(1):127–34.

    PubMed  CAS  Google Scholar 

  35. Kennedy SM, O’Driscoll L, Purcell R, Fitz-Simons N, McDermott EW, Hill AD, O’Higgins NJ, Parkinson M, Linehan R, Clynes M. Prognostic importance of survivin in breast cancer. Br J Cancer. 2003;88:1077–83.

    Article  PubMed  CAS  Google Scholar 

  36. Riedl SJ, Renatus M, Schvanzenbacher R, Zhou Q, Sun C, Fesik SW, et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell. 2001;104:791–800.

    Article  PubMed  CAS  Google Scholar 

  37. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z, Alnemri ES. Molecular determinants of the caspase-promoting activity of SMAC/DIABLO and its role in the death receptor pathway. J Biol Chem. 2000;275:36152–7.

    Article  PubMed  CAS  Google Scholar 

  38. Huang Y, Park YC, Rich RL, Segal D, Myszak DG, Wu H. Structural basis of caspase inhibition by XIAP; differential role of linker versus the BIR domain. Cell. 2001;104:781–90.

    PubMed  CAS  Google Scholar 

  39. Kashkar H, Haefs C. XIAP-mediated caspase inhibition in Hodgkin’s lymphoma-derived B cells. J Exp Med. 2003;198:341–7.

    Article  PubMed  CAS  Google Scholar 

  40. Chauhan D, Li G, Hideshima T, Podar K, Mitsiades C, Mitsiades N, et al. JNK-dependent release of mitochondrial protein, SMAC, during apoptosis in multiple myeloma (MM) cells. J Biol Chem. 2003;278:17593–6.

    Article  PubMed  CAS  Google Scholar 

  41. Yoo NJ, Kim HS, Kim SY. Immunohistochemical analysis of SMAC/DIABLO expression in human carcinomas and sarcomas. APMIS. 2003;111:382–8.

    Article  PubMed  CAS  Google Scholar 

  42. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 1998;351:882–3.

    Article  PubMed  CAS  Google Scholar 

  43. Ryan B, Konecny E, Kahlert S, Wang J, Untch M, Meng G, Pegram M, Podratz K, Crown J, Salmon D, Duffy M. Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol. 2006;17:597–604.

    Article  PubMed  CAS  Google Scholar 

  44. Zhao JM, Zhu ZH, Wu QL, Hou JH, Huang XP, Zhang PY, Rong TH. Expression of Smac in stage I-II non-small cell lung cancer and its clinical significance. Ai Zheng. 2006;25(5):631–4.

    PubMed  CAS  Google Scholar 

  45. Lee CW, Raskett CM, Prudovsky I, Altieri DC. Molecular dependence of estrogen receptor—negative breast cancer on a notch-survivin signaling axis. Cancer Res. 2008;68(13):5273–81.

    Article  PubMed  CAS  Google Scholar 

  46. Xie W, Jiang P, Miao L, Zhao Y, Zhimin Z, Qing L, Zhu WG, Wu M. Proapoptotic SMAC/DIABLO is transcriptionally upregulated by E2F1. Nucleic Acids Res. 2006;34(7):2046–55.

    Article  PubMed  CAS  Google Scholar 

  47. Neubauer NL, Ward EC, Patel P, Lu Z, Lee I, Blok LJ, Hanifi-Moghaddam P, Schink J, Kim JJ. Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis. Horm Cancer. 2011;2(3):170–81. doi:10.1007/s12672-011-0065-7.

    Article  PubMed  CAS  Google Scholar 

  48. Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA. 2007;297(7):724–32.

    Article  PubMed  CAS  Google Scholar 

  49. Sohn DM, Kim SY, Baek MJ, Lim CW, Lee MH, Cho MS, Kim TY. Expression of surviving and clinical correlation in patients with breast cancer. Biomed Pharmacother. 2006;60(6):289–92.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Medical Biochemistry Department, Faculty of Medicine, Ain Shams University, Abbassia, Cairo, 11381, Egypt

    A. Mansour, M. Nabil, R. Ali-Labib & H. Said

  2. Surgery Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    F. Annos

Authors
  1. A. Mansour
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Nabil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Ali-Labib
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Said
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Annos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Mansour.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mansour, A., Nabil, M., Ali-Labib, R. et al. Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer. Med Oncol 29, 2535–2542 (2012). https://doi.org/10.1007/s12032-011-0129-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-011-0129-0

Keywords

Search

Navigation